Patent · US Expired

Use of anticoagulant agents in the extracorporeal treatment of blood

US6809076B2 · kind B2 · utility

3Cited by

8References

9Claims

0Family size

Assignee

Abbott GmbH & Co. KG · DE

Inventors

Rudi Scherhag · Schriesheim, DE
Peter Bacher · Portland, US
Christopher Parow · Speyer, DE
Hans-Ulrich Esslinger · Schallstadt, DE
Florian Abel · Stuttgart, DE

Key dates

Filing date	Mar 20, 2001
Grant date	Oct 26, 2004
Priority date	—
Expiry date	Apr 16, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/60
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of anticoagulant agents for the treatment of individuals with extracorporeal circulation as anticoagulant during the extracorporeal circulation and for prophylaxis of vascular complications after the extracorporeal circulation. It is thus possible in particular to treat individuals with chronic renal insufficiency requiring regular hemodialysis and moreover prevent vascular complications which, on use of conventional anticoagulants, result in a high morbidity and mortality rate for dialysis patients treated longer-term.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.